[Esophageal mycoses after irradiation for cancers of the O.R.L. region. 3 cases].
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D002177:Candidiasis / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D003036:Cobalt Isotopes / Q000627:therapeutic use; D004935:Esophageal Diseases / Q000209:etiology*; D004941:Esophagitis / Q000139:chemically induced / Q000175:diagnosis / Q000209:etiology; D004945:Esophagoscopy; D005938:Glucocorticoids / Q000009:adverse effects; D006801:Humans; D008048:Lip Neoplasms / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D009761:Nystatin / Q000627:therapeutic use; D010610:Pharyngeal Neoplasms / Q000532:radiotherapy; D011878:Radiotherapy / Q000009:adverse effects*; D014067:Tonsillar Neoplasms / Q000532:radiotherapy
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D003036:Cobalt Isotopes; D005938:Glucocorticoids; D009761:Nystatin
Mycoses oesophagiennes après irradiation pour des cancers de la sphère O.R.L. A propos de 3 cas.